BIO experts weigh in on what to expect during JPM Week and how biotech could boost the economy. Plus, BIO’s John Crowley joined the White House Cell and Gene Therapy Forum last week. (646 words, 3 ...

Welcome back, and Happy 2025. We kick off the new year with a look back at some news you might have missed during the break: USMCA dispute panel halted Mexico’s biotech corn ban, what happened with ...

BIO's 1,000 member companies fall into one of four categories: Corporate, Affiliate, Center, or Associate. Membership is only available to organizations. We do not offer individual memberships.

Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) ...

Before we head out for the holidays, we're back with some breaking news about a few of BIO's legislative priorities. Happy Holidays and Happy New Year! We'll see you in 2025 (unless there's major ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a ...

A busy Monday brings louder calls for PBM reform, plus a report on U.S. biotech economic output and jobs, news on avian flu and plant biotech regulations, and more. (834 words, 4 minutes, 10 seconds) ...

Before you begin your Thanksgiving prep, we recap last week's Clinical Trial Diversity Summit, how the "faceless middleman" is raising your healthcare costs, and promising news from USDA. (890 words, ...

Prior to the case study exercise, Silas Buchanan Founding CEO of the Institute for eHealth Equity will provide a framework to use for underserved-community outreach and how to avoid failure points. He ...

In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors. The Full BIO Board of Directors is comprised of all ...

A collaborative initiative to advance corporate board diversity through partnerships and more.

This is the only conference focused specifically on intellectual property in biotechnology, featuring the latest insights from biotech IP experts, as well as networking events designed to promote ...